Mirahype S 50/5 Tablet ER
Marketer
Covaxl Pharma
Salt Composition
Mirabegron (50mg) + Solifenacin (5mg)
Overview Mirahype S 50/5 Tablet ER
Mirahype S 50/5 Extended-Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication alleviates urinary frequency, urgency, and incontinence. Always adhere to your physician's prescribed dosage and duration. It can be administered with or without food, ideally at the same time daily. Discontinuing treatment prematurely, without consulting your doctor, may exacerbate symptoms. Complete the prescribed course for optimal results. Potential side effects include elevated blood pressure, upper respiratory inflammation (affecting the nose and throat), urinary tract infections, and headaches. Report any persistent or troublesome side effects to your doctor immediately. Before starting treatment, disclose all other medications and pre-existing health conditions. Pregnant or breastfeeding individuals should inform their physician before commencing treatment. Patients with liver or kidney impairment require careful monitoring and regular check-ups under medical supervision.
Uses of Mirahype S 50/5 Tablet ER
Bladder control issues
Major Benefits of Mirahype S 50/5 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirahype S 50/5 Tablet ER. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
Common Side effects of Mirahype S 50/5 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Mirahype S 50/5 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirahype S 50/5 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this extended-release tablet can be taken with or without food, consistency in timing is recommended.
How Mirahype S 50/5 Tablet ER works:
Mirabegron and Solifenacin, the components of Mirahype S 50/5 Extended-Release tablets, address overactive bladder symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through a different mechanism. The combined action of these medications reduces the frequency and urgency of urination, offering relief from incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mirahype S 50/5 Tablet ER with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Mirahype S 50/5 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Mirahype S 50/5 Tablet ER with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Mirahype S 50/5 Tablet ER's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Mirahype S 50/5 Tablet ER use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Mirahype S 50/5 Tablet ER use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Mirahype S 50/5 Tablet ER :
NA
Facts to Know About Mirahype S 50/5 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urological Care |


